Induction of remission in autoimmune polyglandular syndrome type three (APS III): An old drug with new perspectives
Key Clinical Message The autoimmune polyglandular syndrome is a sequential chain of autoimmune events. Whenever diagnosed, the clinician's target should be induction of remission and if possible hindering its progression especially if associated with refractory vitiligo, resistant Grave's, or unexpl...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wiley
2018-11-01
|
| Cyfres: | Clinical Case Reports |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1002/ccr3.1827 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
